Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
USNA 
USANA Health Sciences Inc (USNA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/08/2025: USNA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $61
1 Year Target Price $61
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.3% | Avg. Invested days 32 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/08/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 610.28M USD | Price to earnings Ratio 17.65 | 1Y Target Price 61 |
Price to earnings Ratio 17.65 | 1Y Target Price 61 | ||
Volume (30-day avg) 1 | Beta 0.64 | 52 Weeks Range 23.10 - 48.85 | Updated Date 07/8/2025 |
52 Weeks Range 23.10 - 48.85 | Updated Date 07/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.82 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.98% | Operating Margin (TTM) 6.28% |
Management Effectiveness
Return on Assets (TTM) 5.21% | Return on Equity (TTM) 6.42% |
Valuation
Trailing PE 17.65 | Forward PE 12.32 | Enterprise Value 441746399 | Price to Sales(TTM) 0.7 |
Enterprise Value 441746399 | Price to Sales(TTM) 0.7 | ||
Enterprise Value to Revenue 0.5 | Enterprise Value to EBITDA 4.7 | Shares Outstanding 18623100 | Shares Floating 9853469 |
Shares Outstanding 18623100 | Shares Floating 9853469 | ||
Percent Insiders 42.12 | Percent Institutions 58.65 |
Upturn AI SWOT
USANA Health Sciences Inc
Company Overview
History and Background
USANA Health Sciences Inc. was founded in 1992 by Dr. Myron Wentz. Initially focused on producing high-quality nutritional supplements, the company expanded through a direct selling model and international expansion. It has grown to become a significant player in the health and wellness industry.
Core Business Areas
- Nutritional Supplements: USANA's core business is the development and manufacturing of nutritional supplements, including vitamins, minerals, and antioxidants.
- Personal Care Products: USANA also offers a range of personal care products, including skincare and hair care items.
- Active Nutrition Products: Focuses on energy drinks, protein bars, and related products designed for active lifestyles.
Leadership and Structure
The leadership team consists of Jim Brown (President and CEO), Walter Noot (Chief Operating Officer), and Paul Jones (Chief Financial Officer). USANA operates under a direct selling model with a network of independent distributors.
Top Products and Market Share
Key Offerings
- CellSentials: A flagship nutritional supplement product, CellSentials provides essential vitamins and minerals. Estimated annual revenue from this product line is $200 million. Competitors include Centrum and One A Day.
- Market Share (%): 2
- Market Share (%): 0.9
- USANA Probiotic: A digestive health supplement designed to support gut health. Estimated annual revenue from this product is $25 million. Competitors include Culturelle and Align.
- Celavive Skincare: A comprehensive skincare line featuring advanced skincare technology. Competitors include Rodan + Fields and Nu Skin.
- Market Share (%): 0.5
Market Dynamics
Industry Overview
The global nutritional supplements market is experiencing steady growth, driven by increasing health awareness and aging populations. The market is highly competitive, with numerous players offering a wide range of products.
Positioning
USANA is positioned as a premium nutritional supplement provider, emphasizing science-based formulations and quality manufacturing. Its direct selling model offers a unique distribution approach, but also presents challenges in maintaining distributor engagement.
Total Addressable Market (TAM)
The global nutritional supplements market is estimated at $163.9 billion in 2023 and is expected to reach $242.6 billion by 2032. USANA's market capitalization represents a small portion of this large addressable market, indicating significant growth potential but also substantial competition.
Upturn SWOT Analysis
Strengths
- High-quality products
- Strong brand reputation
- Science-based formulations
- Direct selling model
- International presence
Weaknesses
- Reliance on direct selling model
- Price point compared to competitors
- Regulatory scrutiny
- Distributor turnover
- Market share is relatively small compared to larger companies.
Opportunities
- Expanding into new markets
- Developing new product lines
- Increasing online presence
- Capitalizing on growing health awareness
- Strategic Partnerships
Threats
- Intense competition
- Changing consumer preferences
- Economic downturns
- Regulatory changes
- Negative publicity regarding direct selling
Competitors and Market Share
Key Competitors
- HLF
- NUS
- NWL
Competitive Landscape
USANA differentiates itself through science-backed products and direct sales. However, it faces significant competition from larger companies with greater resources and brand recognition.
Major Acquisitions
None
- Year: 2024
- Acquisition Price (USD millions): 0
- Strategic Rationale: There have not been any recent acquisitions.
Growth Trajectory and Initiatives
Historical Growth: USANA's growth has been driven by international expansion and new product introductions. However, the company has faced challenges in maintaining consistent growth due to economic fluctuations and distributor churn.
Future Projections: Analysts anticipate moderate revenue growth in the coming years, driven by expansion in Asia and new product launches. EPS is expected to increase as the company optimizes its operations and improves profitability.
Recent Initiatives: USANA has focused on enhancing its online presence, improving distributor training, and developing innovative products to address evolving consumer needs.
Summary
USANA is a reputable company with science-backed products and a direct selling model. While it has a strong brand and international presence, its reliance on direct selling and relatively small market share pose challenges. The company's financial health is good, but revenue growth needs to be consistent, and it must look out for intense competition and regulatory changes in the direct selling space.
Peer Comparison
Sources and Disclaimers
Data Sources:
- USANA Health Sciences Inc. SEC Filings
- Market Research Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on your own research and due diligence. Market data can fluctuate and may not be entirely accurate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About USANA Health Sciences Inc
Exchange NYSE | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & President Mr. Jim Brown | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 1700 | Website https://www.usana.com |
Full time employees 1700 | Website https://www.usana.com | ||
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.